ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Prescription Medicine Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-31K9957
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Prescription Medicine Market Insights Forecast to 2028
BUY CHAPTERS

Global Prescription Medicine Market Research Report 2025

Code: QYRE-Auto-31K9957
Report
July 2025
Pages:111
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Pfizer Inc
Roche
Novartis
Johnson & Johnson
Merck
Sanofi
AbbVie
GlaxoSmithKline PLC
Amgen Inc
Gilead Science
Bristol–Myers Squibb
Astrazeneca plc
Eli Lilly
Bayer
Novo Nordisk
Takeda
Boehringer Ingelheim
Allergan plc
Teva Pharmaceutical Industries
Mylan NV
Astellas Pharma
Biogen
CSL Limited
Daiichi Sankyo
Otsuka Holdings
UCB
Les Laboratoires Servier
Bausch Health Companies
Eisai Co Ltd
Abbott Laboratories

Prescription Medicine Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Prescription Medicine Market

Prescription Medicine Market

The global market for Prescription Medicine was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Prescription Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prescription Medicine.
The Prescription Medicine market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Prescription Medicine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Prescription Medicine companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Prescription Medicine Market Report

Report Metric Details
Report Name Prescription Medicine Market
CAGR 5%
Segment by Type
Segment by Application
  • Hospital
  • Clinic
  • Online
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Pfizer, Roche, Novartis, Johnson & Johnson, Merck & Co., Sanofi, AbbVie, GlaxoSmithKline, Amgen, Gilead Science, Bristol-Myers Squibb, AstraZeneca, Eli Lilly, Bayer, Novo Nordisk, Takeda, Boehringer-Ingelheim, Allergan, Teva Pharmaceutical Industries, Mylan, Astellas Pharma, Biogen, CSL, Daiichi Sankyo, Otsuka Holdings, UCB, LES LABORATOIRES SERVIER, Bausch Health Companies, Eisai, Abbott Laboratories
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Prescription Medicine company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Prescription Medicine Market report?

Ans: The main players in the Prescription Medicine Market are Pfizer, Roche, Novartis, Johnson & Johnson, Merck & Co., Sanofi, AbbVie, GlaxoSmithKline, Amgen, Gilead Science, Bristol-Myers Squibb, AstraZeneca, Eli Lilly, Bayer, Novo Nordisk, Takeda, Boehringer-Ingelheim, Allergan, Teva Pharmaceutical Industries, Mylan, Astellas Pharma, Biogen, CSL, Daiichi Sankyo, Otsuka Holdings, UCB, LES LABORATOIRES SERVIER, Bausch Health Companies, Eisai, Abbott Laboratories

What are the Application segmentation covered in the Prescription Medicine Market report?

Ans: The Applications covered in the Prescription Medicine Market report are Hospital, Clinic, Online, Others

What are the Type segmentation covered in the Prescription Medicine Market report?

Ans: The Types covered in the Prescription Medicine Market report are Original Brand Drug, Generic Drug

Recommended Reports

Disease-specific Drugs

Pharmaceutical Equipment & Compliance

Therapeutic & Anti-Infectives

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Prescription Medicine Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Original Brand Drug
1.2.3 Generic Drug
1.3 Market by Application
1.3.1 Global Prescription Medicine Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Online
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Prescription Medicine Market Perspective (2020-2031)
2.2 Global Prescription Medicine Growth Trends by Region
2.2.1 Global Prescription Medicine Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Prescription Medicine Historic Market Size by Region (2020-2025)
2.2.3 Prescription Medicine Forecasted Market Size by Region (2026-2031)
2.3 Prescription Medicine Market Dynamics
2.3.1 Prescription Medicine Industry Trends
2.3.2 Prescription Medicine Market Drivers
2.3.3 Prescription Medicine Market Challenges
2.3.4 Prescription Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Prescription Medicine Players by Revenue
3.1.1 Global Top Prescription Medicine Players by Revenue (2020-2025)
3.1.2 Global Prescription Medicine Revenue Market Share by Players (2020-2025)
3.2 Global Prescription Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Prescription Medicine Revenue
3.4 Global Prescription Medicine Market Concentration Ratio
3.4.1 Global Prescription Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Prescription Medicine Revenue in 2024
3.5 Global Key Players of Prescription Medicine Head office and Area Served
3.6 Global Key Players of Prescription Medicine, Product and Application
3.7 Global Key Players of Prescription Medicine, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Prescription Medicine Breakdown Data by Type
4.1 Global Prescription Medicine Historic Market Size by Type (2020-2025)
4.2 Global Prescription Medicine Forecasted Market Size by Type (2026-2031)
5 Prescription Medicine Breakdown Data by Application
5.1 Global Prescription Medicine Historic Market Size by Application (2020-2025)
5.2 Global Prescription Medicine Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Prescription Medicine Market Size (2020-2031)
6.2 North America Prescription Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Prescription Medicine Market Size by Country (2020-2025)
6.4 North America Prescription Medicine Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Prescription Medicine Market Size (2020-2031)
7.2 Europe Prescription Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Prescription Medicine Market Size by Country (2020-2025)
7.4 Europe Prescription Medicine Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Prescription Medicine Market Size (2020-2031)
8.2 Asia-Pacific Prescription Medicine Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Prescription Medicine Market Size by Region (2020-2025)
8.4 Asia-Pacific Prescription Medicine Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Prescription Medicine Market Size (2020-2031)
9.2 Latin America Prescription Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Prescription Medicine Market Size by Country (2020-2025)
9.4 Latin America Prescription Medicine Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Prescription Medicine Market Size (2020-2031)
10.2 Middle East & Africa Prescription Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Prescription Medicine Market Size by Country (2020-2025)
10.4 Middle East & Africa Prescription Medicine Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Prescription Medicine Introduction
11.1.4 Pfizer Revenue in Prescription Medicine Business (2020-2025)
11.1.5 Pfizer Recent Development
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Roche Business Overview
11.2.3 Roche Prescription Medicine Introduction
11.2.4 Roche Revenue in Prescription Medicine Business (2020-2025)
11.2.5 Roche Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Prescription Medicine Introduction
11.3.4 Novartis Revenue in Prescription Medicine Business (2020-2025)
11.3.5 Novartis Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Details
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Prescription Medicine Introduction
11.4.4 Johnson & Johnson Revenue in Prescription Medicine Business (2020-2025)
11.4.5 Johnson & Johnson Recent Development
11.5 Merck & Co.
11.5.1 Merck & Co. Company Details
11.5.2 Merck & Co. Business Overview
11.5.3 Merck & Co. Prescription Medicine Introduction
11.5.4 Merck & Co. Revenue in Prescription Medicine Business (2020-2025)
11.5.5 Merck & Co. Recent Development
11.6 Sanofi
11.6.1 Sanofi Company Details
11.6.2 Sanofi Business Overview
11.6.3 Sanofi Prescription Medicine Introduction
11.6.4 Sanofi Revenue in Prescription Medicine Business (2020-2025)
11.6.5 Sanofi Recent Development
11.7 AbbVie
11.7.1 AbbVie Company Details
11.7.2 AbbVie Business Overview
11.7.3 AbbVie Prescription Medicine Introduction
11.7.4 AbbVie Revenue in Prescription Medicine Business (2020-2025)
11.7.5 AbbVie Recent Development
11.8 GlaxoSmithKline
11.8.1 GlaxoSmithKline Company Details
11.8.2 GlaxoSmithKline Business Overview
11.8.3 GlaxoSmithKline Prescription Medicine Introduction
11.8.4 GlaxoSmithKline Revenue in Prescription Medicine Business (2020-2025)
11.8.5 GlaxoSmithKline Recent Development
11.9 Amgen
11.9.1 Amgen Company Details
11.9.2 Amgen Business Overview
11.9.3 Amgen Prescription Medicine Introduction
11.9.4 Amgen Revenue in Prescription Medicine Business (2020-2025)
11.9.5 Amgen Recent Development
11.10 Gilead Science
11.10.1 Gilead Science Company Details
11.10.2 Gilead Science Business Overview
11.10.3 Gilead Science Prescription Medicine Introduction
11.10.4 Gilead Science Revenue in Prescription Medicine Business (2020-2025)
11.10.5 Gilead Science Recent Development
11.11 Bristol-Myers Squibb
11.11.1 Bristol-Myers Squibb Company Details
11.11.2 Bristol-Myers Squibb Business Overview
11.11.3 Bristol-Myers Squibb Prescription Medicine Introduction
11.11.4 Bristol-Myers Squibb Revenue in Prescription Medicine Business (2020-2025)
11.11.5 Bristol-Myers Squibb Recent Development
11.12 AstraZeneca
11.12.1 AstraZeneca Company Details
11.12.2 AstraZeneca Business Overview
11.12.3 AstraZeneca Prescription Medicine Introduction
11.12.4 AstraZeneca Revenue in Prescription Medicine Business (2020-2025)
11.12.5 AstraZeneca Recent Development
11.13 Eli Lilly
11.13.1 Eli Lilly Company Details
11.13.2 Eli Lilly Business Overview
11.13.3 Eli Lilly Prescription Medicine Introduction
11.13.4 Eli Lilly Revenue in Prescription Medicine Business (2020-2025)
11.13.5 Eli Lilly Recent Development
11.14 Bayer
11.14.1 Bayer Company Details
11.14.2 Bayer Business Overview
11.14.3 Bayer Prescription Medicine Introduction
11.14.4 Bayer Revenue in Prescription Medicine Business (2020-2025)
11.14.5 Bayer Recent Development
11.15 Novo Nordisk
11.15.1 Novo Nordisk Company Details
11.15.2 Novo Nordisk Business Overview
11.15.3 Novo Nordisk Prescription Medicine Introduction
11.15.4 Novo Nordisk Revenue in Prescription Medicine Business (2020-2025)
11.15.5 Novo Nordisk Recent Development
11.16 Takeda
11.16.1 Takeda Company Details
11.16.2 Takeda Business Overview
11.16.3 Takeda Prescription Medicine Introduction
11.16.4 Takeda Revenue in Prescription Medicine Business (2020-2025)
11.16.5 Takeda Recent Development
11.17 Boehringer-Ingelheim
11.17.1 Boehringer-Ingelheim Company Details
11.17.2 Boehringer-Ingelheim Business Overview
11.17.3 Boehringer-Ingelheim Prescription Medicine Introduction
11.17.4 Boehringer-Ingelheim Revenue in Prescription Medicine Business (2020-2025)
11.17.5 Boehringer-Ingelheim Recent Development
11.18 Allergan
11.18.1 Allergan Company Details
11.18.2 Allergan Business Overview
11.18.3 Allergan Prescription Medicine Introduction
11.18.4 Allergan Revenue in Prescription Medicine Business (2020-2025)
11.18.5 Allergan Recent Development
11.19 Teva Pharmaceutical Industries
11.19.1 Teva Pharmaceutical Industries Company Details
11.19.2 Teva Pharmaceutical Industries Business Overview
11.19.3 Teva Pharmaceutical Industries Prescription Medicine Introduction
11.19.4 Teva Pharmaceutical Industries Revenue in Prescription Medicine Business (2020-2025)
11.19.5 Teva Pharmaceutical Industries Recent Development
11.20 Mylan
11.20.1 Mylan Company Details
11.20.2 Mylan Business Overview
11.20.3 Mylan Prescription Medicine Introduction
11.20.4 Mylan Revenue in Prescription Medicine Business (2020-2025)
11.20.5 Mylan Recent Development
11.21 Astellas Pharma
11.21.1 Astellas Pharma Company Details
11.21.2 Astellas Pharma Business Overview
11.21.3 Astellas Pharma Prescription Medicine Introduction
11.21.4 Astellas Pharma Revenue in Prescription Medicine Business (2020-2025)
11.21.5 Astellas Pharma Recent Development
11.22 Biogen
11.22.1 Biogen Company Details
11.22.2 Biogen Business Overview
11.22.3 Biogen Prescription Medicine Introduction
11.22.4 Biogen Revenue in Prescription Medicine Business (2020-2025)
11.22.5 Biogen Recent Development
11.23 CSL
11.23.1 CSL Company Details
11.23.2 CSL Business Overview
11.23.3 CSL Prescription Medicine Introduction
11.23.4 CSL Revenue in Prescription Medicine Business (2020-2025)
11.23.5 CSL Recent Development
11.24 Daiichi Sankyo
11.24.1 Daiichi Sankyo Company Details
11.24.2 Daiichi Sankyo Business Overview
11.24.3 Daiichi Sankyo Prescription Medicine Introduction
11.24.4 Daiichi Sankyo Revenue in Prescription Medicine Business (2020-2025)
11.24.5 Daiichi Sankyo Recent Development
11.25 Otsuka Holdings
11.25.1 Otsuka Holdings Company Details
11.25.2 Otsuka Holdings Business Overview
11.25.3 Otsuka Holdings Prescription Medicine Introduction
11.25.4 Otsuka Holdings Revenue in Prescription Medicine Business (2020-2025)
11.25.5 Otsuka Holdings Recent Development
11.26 UCB
11.26.1 UCB Company Details
11.26.2 UCB Business Overview
11.26.3 UCB Prescription Medicine Introduction
11.26.4 UCB Revenue in Prescription Medicine Business (2020-2025)
11.26.5 UCB Recent Development
11.27 LES LABORATOIRES SERVIER
11.27.1 LES LABORATOIRES SERVIER Company Details
11.27.2 LES LABORATOIRES SERVIER Business Overview
11.27.3 LES LABORATOIRES SERVIER Prescription Medicine Introduction
11.27.4 LES LABORATOIRES SERVIER Revenue in Prescription Medicine Business (2020-2025)
11.27.5 LES LABORATOIRES SERVIER Recent Development
11.28 Bausch Health Companies
11.28.1 Bausch Health Companies Company Details
11.28.2 Bausch Health Companies Business Overview
11.28.3 Bausch Health Companies Prescription Medicine Introduction
11.28.4 Bausch Health Companies Revenue in Prescription Medicine Business (2020-2025)
11.28.5 Bausch Health Companies Recent Development
11.29 Eisai
11.29.1 Eisai Company Details
11.29.2 Eisai Business Overview
11.29.3 Eisai Prescription Medicine Introduction
11.29.4 Eisai Revenue in Prescription Medicine Business (2020-2025)
11.29.5 Eisai Recent Development
11.30 Abbott Laboratories
11.30.1 Abbott Laboratories Company Details
11.30.2 Abbott Laboratories Business Overview
11.30.3 Abbott Laboratories Prescription Medicine Introduction
11.30.4 Abbott Laboratories Revenue in Prescription Medicine Business (2020-2025)
11.30.5 Abbott Laboratories Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Pfizer Inc
Roche
Novartis
Johnson & Johnson
Merck
Sanofi
AbbVie
GlaxoSmithKline PLC
Amgen Inc
Gilead Science
Bristol–Myers Squibb
Astrazeneca plc
Eli Lilly
Bayer
Novo Nordisk
Takeda
Boehringer Ingelheim
Allergan plc
Teva Pharmaceutical Industries
Mylan NV
Astellas Pharma
Biogen
CSL Limited
Daiichi Sankyo
Otsuka Holdings
UCB
Les Laboratoires Servier
Bausch Health Companies
Eisai Co Ltd
Abbott Laboratories
List of Tables
 Table 1. Global Prescription Medicine Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Original Brand Drug
 Table 3. Key Players of Generic Drug
 Table 4. Global Prescription Medicine Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Prescription Medicine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Prescription Medicine Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Prescription Medicine Market Share by Region (2020-2025)
 Table 8. Global Prescription Medicine Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Prescription Medicine Market Share by Region (2026-2031)
 Table 10. Prescription Medicine Market Trends
 Table 11. Prescription Medicine Market Drivers
 Table 12. Prescription Medicine Market Challenges
 Table 13. Prescription Medicine Market Restraints
 Table 14. Global Prescription Medicine Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Prescription Medicine Market Share by Players (2020-2025)
 Table 16. Global Top Prescription Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prescription Medicine as of 2024)
 Table 17. Ranking of Global Top Prescription Medicine Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Prescription Medicine Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Prescription Medicine, Headquarters and Area Served
 Table 20. Global Key Players of Prescription Medicine, Product and Application
 Table 21. Global Key Players of Prescription Medicine, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Prescription Medicine Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Prescription Medicine Revenue Market Share by Type (2020-2025)
 Table 25. Global Prescription Medicine Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Prescription Medicine Revenue Market Share by Type (2026-2031)
 Table 27. Global Prescription Medicine Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Prescription Medicine Revenue Market Share by Application (2020-2025)
 Table 29. Global Prescription Medicine Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Prescription Medicine Revenue Market Share by Application (2026-2031)
 Table 31. North America Prescription Medicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Prescription Medicine Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Prescription Medicine Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Prescription Medicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Prescription Medicine Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Prescription Medicine Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Prescription Medicine Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Prescription Medicine Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Prescription Medicine Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Prescription Medicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Prescription Medicine Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Prescription Medicine Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Prescription Medicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Prescription Medicine Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Prescription Medicine Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Pfizer Company Details
 Table 47. Pfizer Business Overview
 Table 48. Pfizer Prescription Medicine Product
 Table 49. Pfizer Revenue in Prescription Medicine Business (2020-2025) & (US$ Million)
 Table 50. Pfizer Recent Development
 Table 51. Roche Company Details
 Table 52. Roche Business Overview
 Table 53. Roche Prescription Medicine Product
 Table 54. Roche Revenue in Prescription Medicine Business (2020-2025) & (US$ Million)
 Table 55. Roche Recent Development
 Table 56. Novartis Company Details
 Table 57. Novartis Business Overview
 Table 58. Novartis Prescription Medicine Product
 Table 59. Novartis Revenue in Prescription Medicine Business (2020-2025) & (US$ Million)
 Table 60. Novartis Recent Development
 Table 61. Johnson & Johnson Company Details
 Table 62. Johnson & Johnson Business Overview
 Table 63. Johnson & Johnson Prescription Medicine Product
 Table 64. Johnson & Johnson Revenue in Prescription Medicine Business (2020-2025) & (US$ Million)
 Table 65. Johnson & Johnson Recent Development
 Table 66. Merck & Co. Company Details
 Table 67. Merck & Co. Business Overview
 Table 68. Merck & Co. Prescription Medicine Product
 Table 69. Merck & Co. Revenue in Prescription Medicine Business (2020-2025) & (US$ Million)
 Table 70. Merck & Co. Recent Development
 Table 71. Sanofi Company Details
 Table 72. Sanofi Business Overview
 Table 73. Sanofi Prescription Medicine Product
 Table 74. Sanofi Revenue in Prescription Medicine Business (2020-2025) & (US$ Million)
 Table 75. Sanofi Recent Development
 Table 76. AbbVie Company Details
 Table 77. AbbVie Business Overview
 Table 78. AbbVie Prescription Medicine Product
 Table 79. AbbVie Revenue in Prescription Medicine Business (2020-2025) & (US$ Million)
 Table 80. AbbVie Recent Development
 Table 81. GlaxoSmithKline Company Details
 Table 82. GlaxoSmithKline Business Overview
 Table 83. GlaxoSmithKline Prescription Medicine Product
 Table 84. GlaxoSmithKline Revenue in Prescription Medicine Business (2020-2025) & (US$ Million)
 Table 85. GlaxoSmithKline Recent Development
 Table 86. Amgen Company Details
 Table 87. Amgen Business Overview
 Table 88. Amgen Prescription Medicine Product
 Table 89. Amgen Revenue in Prescription Medicine Business (2020-2025) & (US$ Million)
 Table 90. Amgen Recent Development
 Table 91. Gilead Science Company Details
 Table 92. Gilead Science Business Overview
 Table 93. Gilead Science Prescription Medicine Product
 Table 94. Gilead Science Revenue in Prescription Medicine Business (2020-2025) & (US$ Million)
 Table 95. Gilead Science Recent Development
 Table 96. Bristol-Myers Squibb Company Details
 Table 97. Bristol-Myers Squibb Business Overview
 Table 98. Bristol-Myers Squibb Prescription Medicine Product
 Table 99. Bristol-Myers Squibb Revenue in Prescription Medicine Business (2020-2025) & (US$ Million)
 Table 100. Bristol-Myers Squibb Recent Development
 Table 101. AstraZeneca Company Details
 Table 102. AstraZeneca Business Overview
 Table 103. AstraZeneca Prescription Medicine Product
 Table 104. AstraZeneca Revenue in Prescription Medicine Business (2020-2025) & (US$ Million)
 Table 105. AstraZeneca Recent Development
 Table 106. Eli Lilly Company Details
 Table 107. Eli Lilly Business Overview
 Table 108. Eli Lilly Prescription Medicine Product
 Table 109. Eli Lilly Revenue in Prescription Medicine Business (2020-2025) & (US$ Million)
 Table 110. Eli Lilly Recent Development
 Table 111. Bayer Company Details
 Table 112. Bayer Business Overview
 Table 113. Bayer Prescription Medicine Product
 Table 114. Bayer Revenue in Prescription Medicine Business (2020-2025) & (US$ Million)
 Table 115. Bayer Recent Development
 Table 116. Novo Nordisk Company Details
 Table 117. Novo Nordisk Business Overview
 Table 118. Novo Nordisk Prescription Medicine Product
 Table 119. Novo Nordisk Revenue in Prescription Medicine Business (2020-2025) & (US$ Million)
 Table 120. Novo Nordisk Recent Development
 Table 121. Takeda Company Details
 Table 122. Takeda Business Overview
 Table 123. Takeda Prescription Medicine Product
 Table 124. Takeda Revenue in Prescription Medicine Business (2020-2025) & (US$ Million)
 Table 125. Takeda Recent Development
 Table 126. Boehringer-Ingelheim Company Details
 Table 127. Boehringer-Ingelheim Business Overview
 Table 128. Boehringer-Ingelheim Prescription Medicine Product
 Table 129. Boehringer-Ingelheim Revenue in Prescription Medicine Business (2020-2025) & (US$ Million)
 Table 130. Boehringer-Ingelheim Recent Development
 Table 131. Allergan Company Details
 Table 132. Allergan Business Overview
 Table 133. Allergan Prescription Medicine Product
 Table 134. Allergan Revenue in Prescription Medicine Business (2020-2025) & (US$ Million)
 Table 135. Allergan Recent Development
 Table 136. Teva Pharmaceutical Industries Company Details
 Table 137. Teva Pharmaceutical Industries Business Overview
 Table 138. Teva Pharmaceutical Industries Prescription Medicine Product
 Table 139. Teva Pharmaceutical Industries Revenue in Prescription Medicine Business (2020-2025) & (US$ Million)
 Table 140. Teva Pharmaceutical Industries Recent Development
 Table 141. Mylan Company Details
 Table 142. Mylan Business Overview
 Table 143. Mylan Prescription Medicine Product
 Table 144. Mylan Revenue in Prescription Medicine Business (2020-2025) & (US$ Million)
 Table 145. Mylan Recent Development
 Table 146. Astellas Pharma Company Details
 Table 147. Astellas Pharma Business Overview
 Table 148. Astellas Pharma Prescription Medicine Product
 Table 149. Astellas Pharma Revenue in Prescription Medicine Business (2020-2025) & (US$ Million)
 Table 150. Astellas Pharma Recent Development
 Table 151. Biogen Company Details
 Table 152. Biogen Business Overview
 Table 153. Biogen Prescription Medicine Product
 Table 154. Biogen Revenue in Prescription Medicine Business (2020-2025) & (US$ Million)
 Table 155. Biogen Recent Development
 Table 156. CSL Company Details
 Table 157. CSL Business Overview
 Table 158. CSL Prescription Medicine Product
 Table 159. CSL Revenue in Prescription Medicine Business (2020-2025) & (US$ Million)
 Table 160. CSL Recent Development
 Table 161. Daiichi Sankyo Company Details
 Table 162. Daiichi Sankyo Business Overview
 Table 163. Daiichi Sankyo Prescription Medicine Product
 Table 164. Daiichi Sankyo Revenue in Prescription Medicine Business (2020-2025) & (US$ Million)
 Table 165. Daiichi Sankyo Recent Development
 Table 166. Otsuka Holdings Company Details
 Table 167. Otsuka Holdings Business Overview
 Table 168. Otsuka Holdings Prescription Medicine Product
 Table 169. Otsuka Holdings Revenue in Prescription Medicine Business (2020-2025) & (US$ Million)
 Table 170. Otsuka Holdings Recent Development
 Table 171. UCB Company Details
 Table 172. UCB Business Overview
 Table 173. UCB Prescription Medicine Product
 Table 174. UCB Revenue in Prescription Medicine Business (2020-2025) & (US$ Million)
 Table 175. UCB Recent Development
 Table 176. LES LABORATOIRES SERVIER Company Details
 Table 177. LES LABORATOIRES SERVIER Business Overview
 Table 178. LES LABORATOIRES SERVIER Prescription Medicine Product
 Table 179. LES LABORATOIRES SERVIER Revenue in Prescription Medicine Business (2020-2025) & (US$ Million)
 Table 180. LES LABORATOIRES SERVIER Recent Development
 Table 181. Bausch Health Companies Company Details
 Table 182. Bausch Health Companies Business Overview
 Table 183. Bausch Health Companies Prescription Medicine Product
 Table 184. Bausch Health Companies Revenue in Prescription Medicine Business (2020-2025) & (US$ Million)
 Table 185. Bausch Health Companies Recent Development
 Table 186. Eisai Company Details
 Table 187. Eisai Business Overview
 Table 188. Eisai Prescription Medicine Product
 Table 189. Eisai Revenue in Prescription Medicine Business (2020-2025) & (US$ Million)
 Table 190. Eisai Recent Development
 Table 191. Abbott Laboratories Company Details
 Table 192. Abbott Laboratories Business Overview
 Table 193. Abbott Laboratories Prescription Medicine Product
 Table 194. Abbott Laboratories Revenue in Prescription Medicine Business (2020-2025) & (US$ Million)
 Table 195. Abbott Laboratories Recent Development
 Table 196. Research Programs/Design for This Report
 Table 197. Key Data Information from Secondary Sources
 Table 198. Key Data Information from Primary Sources
 Table 199. Authors List of This Report


List of Figures
 Figure 1. Prescription Medicine Picture
 Figure 2. Global Prescription Medicine Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Prescription Medicine Market Share by Type: 2024 VS 2031
 Figure 4. Original Brand Drug Features
 Figure 5. Generic Drug Features
 Figure 6. Global Prescription Medicine Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Prescription Medicine Market Share by Application: 2024 VS 2031
 Figure 8. Hospital Case Studies
 Figure 9. Clinic Case Studies
 Figure 10. Online Case Studies
 Figure 11. Others Case Studies
 Figure 12. Prescription Medicine Report Years Considered
 Figure 13. Global Prescription Medicine Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 14. Global Prescription Medicine Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Prescription Medicine Market Share by Region: 2024 VS 2031
 Figure 16. Global Prescription Medicine Market Share by Players in 2024
 Figure 17. Global Top Prescription Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prescription Medicine as of 2024)
 Figure 18. The Top 10 and 5 Players Market Share by Prescription Medicine Revenue in 2024
 Figure 19. North America Prescription Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. North America Prescription Medicine Market Share by Country (2020-2031)
 Figure 21. United States Prescription Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Canada Prescription Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Prescription Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Prescription Medicine Market Share by Country (2020-2031)
 Figure 25. Germany Prescription Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. France Prescription Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. U.K. Prescription Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Italy Prescription Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Russia Prescription Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Nordic Countries Prescription Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Prescription Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Prescription Medicine Market Share by Region (2020-2031)
 Figure 33. China Prescription Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Japan Prescription Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. South Korea Prescription Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Southeast Asia Prescription Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. India Prescription Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Australia Prescription Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Prescription Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Prescription Medicine Market Share by Country (2020-2031)
 Figure 41. Mexico Prescription Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Brazil Prescription Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Prescription Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Prescription Medicine Market Share by Country (2020-2031)
 Figure 45. Turkey Prescription Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Saudi Arabia Prescription Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. UAE Prescription Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Pfizer Revenue Growth Rate in Prescription Medicine Business (2020-2025)
 Figure 49. Roche Revenue Growth Rate in Prescription Medicine Business (2020-2025)
 Figure 50. Novartis Revenue Growth Rate in Prescription Medicine Business (2020-2025)
 Figure 51. Johnson & Johnson Revenue Growth Rate in Prescription Medicine Business (2020-2025)
 Figure 52. Merck & Co. Revenue Growth Rate in Prescription Medicine Business (2020-2025)
 Figure 53. Sanofi Revenue Growth Rate in Prescription Medicine Business (2020-2025)
 Figure 54. AbbVie Revenue Growth Rate in Prescription Medicine Business (2020-2025)
 Figure 55. GlaxoSmithKline Revenue Growth Rate in Prescription Medicine Business (2020-2025)
 Figure 56. Amgen Revenue Growth Rate in Prescription Medicine Business (2020-2025)
 Figure 57. Gilead Science Revenue Growth Rate in Prescription Medicine Business (2020-2025)
 Figure 58. Bristol-Myers Squibb Revenue Growth Rate in Prescription Medicine Business (2020-2025)
 Figure 59. AstraZeneca Revenue Growth Rate in Prescription Medicine Business (2020-2025)
 Figure 60. Eli Lilly Revenue Growth Rate in Prescription Medicine Business (2020-2025)
 Figure 61. Bayer Revenue Growth Rate in Prescription Medicine Business (2020-2025)
 Figure 62. Novo Nordisk Revenue Growth Rate in Prescription Medicine Business (2020-2025)
 Figure 63. Takeda Revenue Growth Rate in Prescription Medicine Business (2020-2025)
 Figure 64. Boehringer-Ingelheim Revenue Growth Rate in Prescription Medicine Business (2020-2025)
 Figure 65. Allergan Revenue Growth Rate in Prescription Medicine Business (2020-2025)
 Figure 66. Teva Pharmaceutical Industries Revenue Growth Rate in Prescription Medicine Business (2020-2025)
 Figure 67. Mylan Revenue Growth Rate in Prescription Medicine Business (2020-2025)
 Figure 68. Astellas Pharma Revenue Growth Rate in Prescription Medicine Business (2020-2025)
 Figure 69. Biogen Revenue Growth Rate in Prescription Medicine Business (2020-2025)
 Figure 70. CSL Revenue Growth Rate in Prescription Medicine Business (2020-2025)
 Figure 71. Daiichi Sankyo Revenue Growth Rate in Prescription Medicine Business (2020-2025)
 Figure 72. Otsuka Holdings Revenue Growth Rate in Prescription Medicine Business (2020-2025)
 Figure 73. UCB Revenue Growth Rate in Prescription Medicine Business (2020-2025)
 Figure 74. LES LABORATOIRES SERVIER Revenue Growth Rate in Prescription Medicine Business (2020-2025)
 Figure 75. Bausch Health Companies Revenue Growth Rate in Prescription Medicine Business (2020-2025)
 Figure 76. Eisai Revenue Growth Rate in Prescription Medicine Business (2020-2025)
 Figure 77. Abbott Laboratories Revenue Growth Rate in Prescription Medicine Business (2020-2025)
 Figure 78. Bottom-up and Top-down Approaches for This Report
 Figure 79. Data Triangulation
 Figure 80. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

Generic Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Influenza Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Diagnostic Guidewire Market Research Report 2024
Inspection System for Pharmaceutical Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Prescription Pain Relievers Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Prescription Dermatology Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Over the Counter Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Computer Vision in Pharmaceutical Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Pharmaceutical Asset Managements Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Coding and Marking for Pharmaceuticals and Consumer Products Market Research Report 2024
Systemic Infection Treatment Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Super Generic Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Still s Disease Treatment Market Research Report 2025
Drug Delivery Technologies Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Pharmaceutical Retail Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
AI for Cancer Diagnosis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Treatment Planning Software Market Research Report 2025
Molecular Diagnosis of Tumors Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Digital Health and Digital Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Ophthalmology Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions